BB Biotech’s Incyte INCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $311M | Sell |
3,620,000
-188,322
| -5% | -$16.2M | 7.83% | 2 |
|
|
2018
Q4 | $242M | Hold |
3,808,322
| – | – | 7.76% | 2 |
|
|
2018
Q3 | $263M | Buy |
3,808,322
+50,000
| +1% | +$3.45M | 6.96% | 5 |
|
|
2018
Q2 | $252M | Buy |
3,758,322
+60,000
| +2% | +$4.02M | 7.27% | 4 |
|
|
2018
Q1 | $308M | Hold |
3,698,322
| – | – | 8.52% | 2 |
|
|
2017
Q4 | $350M | Buy |
3,698,322
+30,000
| +0.8% | +$2.84M | 9.86% | 3 |
|
|
2017
Q3 | $428M | Buy |
3,668,322
+153,500
| +4% | +$17.9M | 11.85% | 2 |
|
|
2017
Q2 | $443M | Buy |
3,514,822
+25,000
| +0.7% | +$3.15M | 13.53% | 1 |
|
|
2017
Q1 | $466M | Sell |
3,489,822
-390,000
| -10% | -$52.1M | 15.26% | 1 |
|
|
2016
Q4 | $389M | Hold |
3,879,822
| – | – | 14.41% | 2 |
|
|
2016
Q3 | $366M | Buy |
3,879,822
+39,416
| +1% | +$3.72M | 12.86% | 1 |
|
|
2016
Q2 | $307M | Hold |
3,840,406
| – | – | 12.12% | 2 |
|
|
2016
Q1 | $278M | Buy |
3,840,406
+90,000
| +2% | +$6.52M | 11.06% | 2 |
|
|
2015
Q4 | $407M | Hold |
3,750,406
| – | – | 11.46% | 2 |
|
|
2015
Q3 | $414M | Buy |
3,750,406
+10,000
| +0.3% | +$1.1M | 13.12% | 1 |
|
|
2015
Q2 | $390M | Sell |
3,740,406
-51,461
| -1% | -$5.36M | 10.57% | 2 |
|
|
2015
Q1 | $348M | Sell |
3,791,867
-260,000
| -6% | -$23.8M | 10.35% | 3 |
|
|
2014
Q4 | $296M | Sell |
4,051,867
-250,000
| -6% | -$18.3M | 9.59% | 3 |
|
|
2014
Q3 | $211M | Buy |
4,301,867
+138,077
| +3% | +$6.77M | 8.58% | 4 |
|
|
2014
Q2 | $235M | Buy |
4,163,790
+30,000
| +0.7% | +$1.69M | 11.17% | 3 |
|
|
2014
Q1 | $221M | Sell |
4,133,790
-87,297
| -2% | -$4.67M | 11.4% | 4 |
|
|
2013
Q4 | $214M | Sell |
4,221,087
-542,183
| -11% | -$27.5M | 11.42% | 4 |
|
|
2013
Q3 | $182M | Sell |
4,763,270
-593,879
| -11% | -$22.7M | 9.89% | 4 |
|
|
2013
Q2 | $118M | Buy |
+5,357,149
| New | +$118M | 8.49% | 4 |
|